
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
Lavinia Spain, Alexander Coulton, Irene Lobón, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1364-1385
Open Access | Times Cited: 37
Lavinia Spain, Alexander Coulton, Irene Lobón, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1364-1385
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada
Immunity (2023) Vol. 56, Iss. 10, pp. 2270-2295
Open Access | Times Cited: 47
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada
Immunity (2023) Vol. 56, Iss. 10, pp. 2270-2295
Open Access | Times Cited: 47
Why do patients with cancer die?
Adrienne Boire, Katy Burke, Thomas R. Cox, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 578-589
Open Access | Times Cited: 27
Adrienne Boire, Katy Burke, Thomas R. Cox, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 578-589
Open Access | Times Cited: 27
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 17
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 17
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, et al.
Nature (2025)
Open Access | Times Cited: 1
Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, et al.
Nature (2025)
Open Access | Times Cited: 1
Whole-genome doubling in tissues and tumors
Marc A. Vittoria, Ryan J. Quinton, Neil J. Ganem
Trends in Genetics (2023) Vol. 39, Iss. 12, pp. 954-967
Open Access | Times Cited: 19
Marc A. Vittoria, Ryan J. Quinton, Neil J. Ganem
Trends in Genetics (2023) Vol. 39, Iss. 12, pp. 954-967
Open Access | Times Cited: 19
Determinants of resistance and response to melanoma therapy
Bailey M. Robertson, Mitchell E. Fane, Ashani T. Weeraratna, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 964-982
Closed Access | Times Cited: 7
Bailey M. Robertson, Mitchell E. Fane, Ashani T. Weeraratna, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 964-982
Closed Access | Times Cited: 7
Insights into the metastatic cascade through research autopsies
Sonya Hessey, Petros Fessas, Simone Zaccaria, et al.
Trends in cancer (2023) Vol. 9, Iss. 6, pp. 490-502
Open Access | Times Cited: 13
Sonya Hessey, Petros Fessas, Simone Zaccaria, et al.
Trends in cancer (2023) Vol. 9, Iss. 6, pp. 490-502
Open Access | Times Cited: 13
Punctuational evolution is pervasive in distal site metastatic colonization
George B. Butler, Sarah R. Amend, Chris Venditti, et al.
Proceedings of the Royal Society B Biological Sciences (2025) Vol. 292, Iss. 2039
Open Access
George B. Butler, Sarah R. Amend, Chris Venditti, et al.
Proceedings of the Royal Society B Biological Sciences (2025) Vol. 292, Iss. 2039
Open Access
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis
Thierry Savy, Lucy Flanders, Thaneswari Karpanasamy, et al.
Trends in cancer (2025)
Open Access
Thierry Savy, Lucy Flanders, Thaneswari Karpanasamy, et al.
Trends in cancer (2025)
Open Access
The Dynamic Landscape of the Coagulome of Metastatic Malignant Melanoma
Jean‐Philippe Arnault, Kimberley Chemmama, Khedidja Ferroudj, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1435-1435
Open Access
Jean‐Philippe Arnault, Kimberley Chemmama, Khedidja Ferroudj, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1435-1435
Open Access
Tracking the Evolution of Cutaneous Melanoma by Multiparameter Flow Sorting and Genomic Profiling
Luca Roma, Thomas Lorber, Sabrina Rau, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1758-1758
Open Access
Luca Roma, Thomas Lorber, Sabrina Rau, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1758-1758
Open Access
A review of BioTree construction in the context of information fusion: Priors, methods, applications and trends
Zelin Zang, Yongjie Xu, Chenrui Duan, et al.
Information Fusion (2025), pp. 103108-103108
Closed Access
Zelin Zang, Yongjie Xu, Chenrui Duan, et al.
Information Fusion (2025), pp. 103108-103108
Closed Access
Advances in sequencing-based studies of microDNA and ecDNA: Databases, identification methods, and integration with single-cell analysis
Rong Jiang, Manqiu Yang, Shufan Zhang, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3073-3080
Open Access | Times Cited: 12
Rong Jiang, Manqiu Yang, Shufan Zhang, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3073-3080
Open Access | Times Cited: 12
Bcl-2 dependent modulation of Hippo pathway in cancer cells
Simona D’Aguanno, Matteo Brignone, Stefano Scalera, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Simona D’Aguanno, Matteo Brignone, Stefano Scalera, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region
Costantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Histopathology (2025)
Closed Access
Costantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Histopathology (2025)
Closed Access
Research autopsy programmes in oncology: shared experience from 14 centres across the world
Tatjana Geukens, Marion Maetens, Jody E. Hooper, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 2, pp. 150-165
Open Access | Times Cited: 3
Tatjana Geukens, Marion Maetens, Jody E. Hooper, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 2, pp. 150-165
Open Access | Times Cited: 3
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan
Tokimasa Hida, Masashi Idogawa, Junji Kato, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 2
Tokimasa Hida, Masashi Idogawa, Junji Kato, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 2
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma
Wei Sun, Yu Zhu, Zijian Zou, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 2127-2150
Open Access | Times Cited: 1
Wei Sun, Yu Zhu, Zijian Zou, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 2127-2150
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Michael Renteln
(2024)
Open Access | Times Cited: 1
Punctuational evolution is pervasive in distal site metastatic colonization
George B. Butler, Sarah R. Amend, Robert Axelrod, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
George B. Butler, Sarah R. Amend, Robert Axelrod, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Michael Renteln
(2024)
Open Access | Times Cited: 1
Somatic structural variants drive distinct modes of oncogenesis in melanoma
Jake R. Conway, Riaz Gillani, Jett Crowdis, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 1
Jake R. Conway, Riaz Gillani, Jett Crowdis, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Michael Renteln
(2024)
Open Access | Times Cited: 1
Targeting Clonal Mutations with Synthetic Microbes
Michael Renteln
(2024)
Open Access | Times Cited: 1
Michael Renteln
(2024)
Open Access | Times Cited: 1
Targeting Clonal Mutations with Synthetic Microbes
Michael Renteln
(2024)
Open Access | Times Cited: 1
Michael Renteln
(2024)
Open Access | Times Cited: 1